Literature DB >> 6423033

Prostacyclin--powerful, yes: but is it useful?

J R Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6423033      PMCID： PMC1550034          DOI： 10.1136/bmj.287.6408.1824

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  14 in total

1.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.

Authors:  S Moncada; J R Vane
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

2.  Prostacyclin is a circulating hormone.

Authors:  S Moncada; R Korbut; S Bunting; J R Vane
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

3.  Prostaglandin E 1 and human platelets.

Authors:  R S Elkeles; J R Hampton; M J Harrison; J R Mitchell
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

4.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

5.  Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.

Authors:  P R Emmons; J R Hampton; M J Harrison; A J Honour; J R Mitchell
Journal:  Br Med J       Date:  1967-05-20

6.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

7.  Epoprostenol (prostacyclin) decreases platelet deposition on vascular prosthetic grafts.

Authors:  H Sinzinger; J O'Grady; M Cromwell; R Hofer
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

8.  Transient hypoxaemia during sleep in chronic bronchitis and emphysema.

Authors:  N J Douglas; P M Calverley; R J Leggett; H M Brash; D C Flenley; V Brezinova
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

9.  Treatment of ischaemic stroke with prostacyclin.

Authors:  R J Gryglewski; S Nowak; E Kostka-Trabka; J Kusmiderski; A Dembinska-Kiec; K Bieron; M Basista; B Blaszczyk
Journal:  Stroke       Date:  1983 Mar-Apr       Impact factor: 7.914

10.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205
View more
  1 in total

Review 1.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.